Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Infect Dis ; 20(1): 21, 2020 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-31910823

RESUMO

BACKGROUND: Meningitis is a very rare atypical presenting feature of anti-NMDA receptor encephalitis. In our case report, we describe an unusual clinical presentation of anti-NMDA receptor encephalitis with a biphasic pattern of meningitis followed by encephalitis and discuss potential mechanisms underlying this presentation. We aim to widen the differential diagnosis to be considered in a patient presenting with clinical meningitis and pyrexia. CASE PRESENTATION: This is a case of a 33-year old Caucasian woman who initially presented with a lymphocytic meningitis attributed to a viral infection. She subsequently developed fluctuating consciousness, agitation, visual hallucinations, dyskinetic movements, a generalized tonic-clonic seizure, and autonomic instability. Investigations revealed a diagnosis of anti-NMDA receptor encephalitis secondary to a previously unidentified ovarian teratoma. She made an excellent recovery with immunotherapy and removal of the teratoma. CONCLUSION: Clinicians should consider autoimmune encephalitides in individuals with meningitis, particularly where extensive investigations fail to identify a causative pathogen and there is rapid development of an encephalitic phenotype.


Assuntos
Encefalite Antirreceptor de N-Metil-D-Aspartato/diagnóstico , Meningite Viral/diagnóstico , Neoplasias Ovarianas/patologia , Teratoma/patologia , Administração Intravenosa , Adulto , Encefalite Antirreceptor de N-Metil-D-Aspartato/complicações , Encefalite Antirreceptor de N-Metil-D-Aspartato/tratamento farmacológico , Anticorpos/sangue , Diagnóstico Diferencial , Encefalite/diagnóstico , Feminino , Febre/diagnóstico , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Doença de Hashimoto/diagnóstico , Humanos , Imunoterapia , Metilprednisolona/administração & dosagem , Metilprednisolona/uso terapêutico , Neoplasias Ovarianas/tratamento farmacológico , Neoplasias Ovarianas/etiologia , Neoplasias Ovarianas/cirurgia , Troca Plasmática , Receptores de N-Metil-D-Aspartato/imunologia , Convulsões/diagnóstico , Teratoma/tratamento farmacológico , Teratoma/etiologia , Teratoma/cirurgia , Resultado do Tratamento
3.
Med Sci Law ; 56(3): 172-7, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26113543

RESUMO

The Mental Health (Care and Treatment) (Scotland) Act 2003 introduced the right for patients in high-security psychiatric care to appeal against detention in conditions of excessive security. A previous study examined the first 100 patients to appeal under this provision. In this study we compare them with the next cohort of 110 patients to lodge an appeal, finding, contrary to expectations, no change in patient characteristics or the outcome of their appeals. The clinical, legal and demographic features of successful and unsuccessful appellants, who made up 38% and 27% of the 110 patients, respectively, were also compared. Those patients with the support of their responsible medical officer and those already included on a transfer list had a significantly better chance of success (p = 0.00). It was also found that a history of excessive alcohol consumption was associated with successful appeals (p = 0.002). A diagnosis of learning disability was associated with unsuccessful appeals (p = 0.018), though the sub-sample was very small. These findings are important given the forthcoming extension of this right of appeal to other levels of security.


Assuntos
Internação Compulsória de Doente Mental/legislação & jurisprudência , Transtornos Mentais , Feminino , Psiquiatria Legal , Humanos , Masculino , Transtornos Mentais/terapia , Escócia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA